Pharmacy foundations Flashcards
Sentinel event
death or serious physical or psychological injury of a patient
Prospective Study
A prospective study watches for outcomes, such as the development of a disease, during the study period and relates this to other factors such as suspected risk or protection factor(s). The study usually involves taking a cohort of subjects and watching them over a long period. Prospective studies usually have fewer potential sources of bias and confounding than retrospective studies.
Retrospective Study
A retrospective study looks backwards and examines exposures to suspected risk or protection factors in relation to an outcome that is established at the start of the study. Most sources of error due to confounding and bias are more common in retrospective studies than in prospective studies.
-EX: case-control studies (but not exclusively)
Continuous
-measure continuous data
-weight, height, length, time, and temperature
-Infinite number of fractional values between any two values.
The Joint Commission (TJC)
independent, not for profit organization that accredits and certifies
-set national patient safety goals annually
high alert medications
Anesthetic inhaled or IV (propofol)
Antiarrhythmics IV (amiodarone)
Anticoagulants/antithrombotics (heparin, warfarin)
Chemotherapy
epidural/intrathecal drugs
hypertonic saline
immunosupressants
inotropics
insulins
mag sulfate
NMBA
opioids
oral hypoglycemic
PN
KCl/KPhos
SWi
5 rights of medication administration
right patient
right time and frequency
right dose
right route
right drug
type A reactions
dose-dependent related to known pharmacologic actions
type B reactions
not dose-dependent, unrelated to the pharmacologic actions
-allergies
-intolerances
-idiosyncratic reactions
Type 1 reactions
IgE-mediated and immediated within 60 min
Type 2 reactions
antibody-mediated occuring several days (5-8 days) after drug expsoure
Type 3 reactions
immune-complex reactions ocurring >1 week after drug exposure
Type 4 reactions
cell-mediated or delayed hypersensitivity reactions, occurring anytime from 48 hr to several weeks after drug exposure
medication guides
FDA-approved patient handouts that details a drug important adverse event
drugs associated with photosensitivity
amiodarone, diuretics, methotrexate, oral and topical retinoids, quinolones, st. johns wort, sulfa antibiotics, tacrolimus, tetracyclines, voriconazole
drugs associated with thrombotic thrombocytopenic purpura (TTP)
oral P2Y12 inhibitors
sulfamethoxazole
drugs commonly associated with severe skin reactions
abacavir, allopurinol, carbamazepine, ethosuximide, lamotrigine, modafinil, nevirapine, penicillins, phenytoin, sulfamethoxazole
Vd
amount of drug in body / concentration of drug in plasma
corrected calcium
= calcium + [(4.0 - albumin) x 0.8]
Cl
dose / AUC
elimination rate constant
ke = cl/ vd
t1/2
= 0.693 / ke
loading dose
= desired concentration x vd / F
HLA-B*5701
Abacavir (containing agents Triumeq, Epzicom)
-incr risk of hypersensitivity reactions
-fatal hypersensitivity reactions
HLA-B*5801
allopurinol (Zyloprim, Aloprim)
-incr risk of SJS
HLA-B*1502
Carbamezapine, oxcarbazepine, phenytoin, fosphenytoin
-incr riskf of SJS and TEN
-most common in asian patients
CYP2C19
clopidogrel
-poor emtabolizers (*2 or *3) have incr risk of cardiovascular events
CYP2D6
codeine
-ultra rapid metbaolizers have incr risk of OD
-infant deaths when nursing mothers who were URM took codeine for pain
CYP2C9*2 and *3 and VORKC1
warfarin
-increased bleeding
HER2
trastuzumab (herceptin)
KRAS
Cetuximab (Erbitux)
DPD deficiency
Capecitabine (Xeloda)
Flurouracil
drugs that require pharmacogenomic testing
abacavir
azathiopurine
carbamazepine
cetuximab and other EGFR inhibitors
trastuzumab and other HER2 inhibitors
supplements that increase bleeding risk
garlic, ginger, ginkgo, ginseng, and glucosamine
fish oils
vitamin E
dong quai
willow bark